These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Serum procalcitonin in diagnosis of bacteremia. Jongwutiwes U; Suitharak K; Tiengrim S; Thamlikitkul V J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S79-87. PubMed ID: 19562990 [TBL] [Abstract][Full Text] [Related]
49. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique]. Borschneck C; Dreyfus M; Bridey F; Edouard D; Meyer D Presse Med; 1995 May 6-13; 24(17):799-802. PubMed ID: 7630868 [TBL] [Abstract][Full Text] [Related]
50. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments]. Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499 [TBL] [Abstract][Full Text] [Related]
52. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis. Rowbotham BJ; Whitaker AN; Masci PP Blood Coagul Fibrinolysis; 1990 Dec; 1(6):653-61. PubMed ID: 2133245 [TBL] [Abstract][Full Text] [Related]
53. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis. Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984 [TBL] [Abstract][Full Text] [Related]